Showing results (191-200 of 376) with videos related to

Sort By:
Pageof 38
Journal of Thrombosis and Haemostasis : JTH|June 26, 2026
Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolismTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|July 30, 2015
Elevated serum creatinine and low albumin are associated with poor outcomes in patients with liposarcomaJoannis Panotopoulos, Florian Posch, Philipp T Funovics, et al.
NMR in Biomedicine|November 8, 2014
Positive contrast of SPIO-labeled cells by off-resonant reconstruction of 3D radial half-echo bSSFPClemens Diwoky, Daniel Liebmann, Bernhard Neumayer, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective studyFlorian Posch, Julia Riedl, Eva-Maria Reitter, et al.
Journal of Thrombosis and Haemostasis : JTH|April 20, 2021
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)Johannes Thaler, Cihan Ay, Karoline V Gleixner, et al.
Journal of Thrombosis and Haemostasis : JTH|May 16, 2023
Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort studyStephan Nopp, Florian Moik, Simon Kraler, et al.
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic reviewBethany R Samuelson Bannow, Agnes Y Y Lee, Alok A Khorana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyJonas Ahlbrecht, Boris Dickmann, Cihan Ay, et al.
International Journal of Molecular Sciences|February 25, 2023
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial FibrillationStephan Nopp, M Leontien van der Bent, Daniel Kraemmer, et al.
Pageof 38